2026-18586NoticeWallet

US Probes Citric Acid Dumping from Canada and India in Trade Fight

Published Date: 9/11/2026

Notice

Summary

The Commission hereby gives notice of the scheduling of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-783-784 and 731-TA-1771-1772 (Final) pursuant to the Tariff Act of 1930 to determine whether an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of citric acid and certain citrate salts, provided for in subheadings 2918.14.00, 2918.15.10, 2918.15.50, and 3824.99.93 of the Harmonized Tariff Schedule of the United States, from China that have been preliminarily determined by the Department of Commerce ("Commerce") to be subsidized by the government of China and sold at less-than-fair-value, and by reason of imports of citric acid and certain citrate salts from Canada that have been preliminarily determined by Commerce to be subsidized by the government of Canada but preliminarily determined by Commerce not to be, or not likely to be, sold at less-than-fair-value.

Analyzed Economic Effects

2 provisions identified: 0 benefits, 1 costs, 1 mixed.

Preliminary Findings on Imports

Commerce has preliminarily found that imports of citric acid and certain citrate salts from China and India have been subsidized and sold at less-than-fair-value, while imports from Canada were preliminarily found subsidized but not sold at less-than-fair-value. The U.S. International Trade Commission has scheduled a final phase to decide whether U.S. industry is materially injured or threatened with material injury by these imports.

Product Scope That’s Covered

The investigation covers all grades and granulation sizes of citric acid, sodium citrate, and potassium citrate, including blends where the unblended citric components make up 40 percent or more by weight, crude calcium citrate intermediates, and products processed in a third country; it excludes calcium citrate that meets United States Pharmacopeia standards and is mixed with a functional excipient that constitutes at least 2 percent by weight. If your imported or manufactured product matches this description, it is explicitly within the scope of these investigations.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Effective Date
Published Date
8/26/2026
9/11/2026

Department and Agencies

Department
Independent Agency
Agency
International Trade Commission
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register